Vanguard Fiduciary Trust »

Apimeds Pharmaceuticals Us I shares owned by Vanguard Fiduciary Trust

Quarter-by-quarter ownership of Apimeds Pharmaceuticals Us I (APUS) shares owned by Vanguard Fiduciary Trust from 13F filings

Historical chart of Vanguard Fiduciary Trust investment in Apimeds Pharmaceuticals Us I

Tip: Access up to 7 years of quarterly data

All positions including Apimeds Pharmaceuticals Us I held by Vanguard Fiduciary Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apimeds Pharmaceuticals Us I by Vanguard Fiduciary Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $43k 24k 1.79

More positions owned by Vanguard Fiduciary Trust

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Fiduciary Trust

Top funds holding Apimeds Pharmaceuticals Us I

Hemenway Trust Company
Vanguard Capital Management
Vanguard Group
Geode Capital Management
Vanguard Fiduciary Trust
Two Sigma Securities
UBS Group
Tower Research Capital

View all funds holding Apimeds Pharmaceuticals Us I